Mean platelet volume (MPV) is associated with leukoaraiosis in the apparently healthy elderly

Seong-Jin Kang1, Byoung-Jin Park, Jae-Yong Shim

  • 1Department of Family Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Insights

Mean platelet volume (MPV) may indicate platelet activity and is linked to inflammation and thrombosis. Higher MPV levels were independently associated with an increased risk of leukoaraiosis, a condition of white matter abnormalities in the brain.

Area of Science:

  • Neurology
  • Hematology
  • Geriatrics

Background:

  • Leukoaraiosis signifies diffuse white matter abnormalities on brain MRI, linked to cerebral microangiopathy and geriatric syndromes.
  • Mean platelet volume (MPV) reflects platelet size and activity, serving as a marker for inflammation and thrombosis in various vascular disorders.

Purpose of the Study:

  • To investigate the association between MPV and leukoaraiosis in healthy elderly individuals.
  • To determine if MPV is an independent predictor of leukoaraiosis.

Main Methods:

  • Cross-sectional study of 223 healthy elderly subjects undergoing health examinations, including brain MRI.
  • Comparison of MPV levels between subjects with and without leukoaraiosis.
  • Multivariate logistic regression analysis to assess the independent association between MPV and leukoaraiosis, adjusting for confounders.

Main Results:

  • The prevalence of leukoaraiosis was 15.3% in the study population.
  • Mean MPV was significantly higher in the leukoaraiosis group (8.4±0.8 fL) compared to the control group (8.1±1.0 fL).
  • A 1 fL increment in MPV was independently associated with a 1.61-fold increased risk of leukoaraiosis (OR 1.61, 95% CI 1.02-2.53).

Conclusions:

  • Mean platelet volume (MPV) is independently and positively associated with leukoaraiosis.
  • Elevated MPV may serve as a useful additional biomarker for assessing leukoaraiosis risk in clinical practice.
  • This finding highlights the potential role of platelet activity in the pathogenesis of white matter abnormalities.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.